Scarica l'app Stockscreener
22.55
4.93%
-1.17
Dopo l'orario di chiusura:
23.08
0.53
+2.35%
Precedente Chiudi:
$23.72
Aprire:
$23.99
Volume 24 ore:
2.82M
Relative Volume:
1.83
Capitalizzazione di mercato:
$1.75B
Reddito:
$1.29B
Utile/perdita netta:
$58.52M
Rapporto P/E:
34.54
EPS:
0.6528
Flusso di cassa netto:
$191.78M
1 W Prestazione:
+19.25%
1M Prestazione:
+38.34%
6M Prestazione:
-5.29%
1 anno Prestazione:
+6.42%
Intervallo 1D:
$22.32
$24.39
Intervallo di 1 settimana:
$18.60
$24.39
Portata 52W:
$16.10
$28.75
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
22.55 | 1.84B | 1.29B | 58.52M | 191.78M | 0.6528 |
UNH
Unitedhealth Group Inc
|
384.44 | 345.08B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
92.22 | 115.54B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
381.75 | 82.10B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
289.07 | 76.20B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
274.26 | 33.01B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
Fertility benefits growth and share buybacks keep Progyny (PGNY) earnings in focus - MSN
PGNY Maintains Rating by Citizens -- Price Target Raised to $31. - GuruFocus
Progyny, Inc.Common Stock (NQ: PGNY - The Chronicle-Journal
Progyny's CEO and CFO to speak at BofA 2026 Health Care Conference on May 12 - Pluang
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference - marketscreener.com
Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference - GlobeNewswire Inc.
Truist Raises Price Target on Progyny to $30 From $28, Keeps Buy Rating - Moomoo
BTIG Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Citizens raises Progyny stock price target on higher EBITDA outlook By Investing.com - Investing.com Nigeria
Citizens raises Progyny stock price target on higher EBITDA outlook - Investing.com
A Look At Progyny (PGNY) Valuation After Raised Guidance And Share Repurchase - Yahoo Finance
Barclays Maintains Progyny(PGNY.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Progyny, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-05-09 - Seeking Alpha
Progyny Earnings Call Signals Confident, Profitable Growth - TipRanks
BofA Securities Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $29 - Moomoo
Progyny (PGNY) Q1 2026 Earnings Call Transcript - AOL.com
Progyny Q1 earnings call highlights - MSN
Progyny Delivers Record Q1 2026 Revenue and Growth - The Globe and Mail
Progyny Q1 Earnings Call Highlights - sharewise.com
CCORF Maintains Progyny(PGNY.US) With Hold Rating, Maintains Target Price $19 - Moomoo
Progyny surges 19% on strong earnings beat - Investing.com UK
Progyny surges 19% on strong earnings beat By Investing.com - Investing.com Canada
Why Is Progyny (PGNY) Stock Soaring Today - TradingView
Progyny | 10-Q: Q1 2026 Earnings Report - Moomoo
Progyny | 8-K: Progyny, Inc. Announces First Quarter 2026 Results - Moomoo
Truist Financial Maintains Progyny(PGNY.US) With Buy Rating - Moomoo
Fertility Benefits Growth and Share Buybacks Keep Progyny (PGNY) Earnings in Focus - Yahoo Finance
Progyny (PGNY) boosts Q1 2026 profit as margins expand and buybacks surge - Stock Titan
Progyny, Inc. 1Q 2026: Revenue $328.5M, EPS $0.29— 10-Q Summary - TradingView
Progyny anticipates 2026 revenue of $1.365B-$1.405B while raising adjusted EBITDA to $232M-$244M - MSN
Progyny (PGNY) Reports Strong Q1 2026 Earnings and Raises Full-Y - GuruFocus
Progyny: Q1 Earnings Snapshot - theheraldreview.com
Understanding the Setup: (PGNY) and Scalable Risk - Stock Traders Daily
Progyny Q1 2026 slides: margin gains offset by investment spending By Investing.com - Investing.com
Progyny bought back 8.8M shares after posting record quarterly revenue - Stock Titan
Earnings call transcript: Progyny Q1 2026 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Progyny Q1 2026 beats EPS forecast, stock dips - Investing.com Australia
Progyny, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Progyny (PGNY) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Progyny Inc (NASDAQ:PGNY) Beats Q1 Estimates and Guides Above Consensus as Selling Season Off to a Strong Start - ChartMill
Progyny (PGNY) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
PROGYNY ($PGNY) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Progyny Q1 revenue slightly beats estimates, raises FY outlook - TradingView
Progyny’s (NASDAQ:PGNY) Q1 CY2026 Sales Beat Estimates, Stock Soars - Yahoo Finance
Earnings Flash (PGNY) Progyny, Inc. Reports Q1 Revenue $328.5M, vs. FactSet Est of $326.5M - marketscreener.com
(PGNY) Progyny, Inc. Expects Q2 Revenue Range $342.0M$355.0M - marketscreener.com
Earnings Flash (PGNY) Progyny, Inc. Posts Q1 Adjusted EPS $0.50 per Share, vs. FactSet Est of $0.26 - marketscreener.com
GUIDANCE: (PGNY) Progyny, Inc. Expects Q2 Revenue Range $342.0M$355.0M - Moomoo
Record Q1 revenue and major buybacks at Progyny (NASDAQ: PGNY) shape 2026 outlook - Stock Titan
Progyny, Inc. Announces First Quarter 2026 Results - The Globe and Mail
Progyny earnings in the spotlight as fertility market heats up By Investing.com - Investing.com Nigeria
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.29%
3.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):